Man Group
PDLI

Man Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Man Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-35,600
Closed -$132K – 2120
2019
Q1 		$132K Sell
35,600
-7,100
-17% -$24K ﹤0.01% 1902
2018
Q4 		$124K Sell
42,700
-49,400
-54% -$136K ﹤0.01% 1843
2018
Q3 		$242K Sell
92,100
-29,500
-24% -$72.4K ﹤0.01% 1991
2018
Q2 		$285K Sell
121,600
-972,040
-89% -$2.71M ﹤0.01% 1937
2018
Q1 		$3.21M Buy
+1,093,640
New +$2.99M 0.01% 1080

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Man Group's PDLI Position: Q2 2019 in Review

Man Group sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 35,600 shares — an estimated $132K sold.

Man Group first reported a position in PDLI in Q1 2018 and held it in 5 quarters. The position peaked at $3.21M in Q1 2018. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Man Group reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Man Group sold 35,600 PDL BioPharma, Inc. shares in Q2 2019, an estimated $132K.
  • Man Group first reported a position in PDL BioPharma, Inc. in Q1 2018 and held it in 5 quarters.
  • Man Group's PDL BioPharma, Inc. position peaked at $3.21M in Q1 2018.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Man Group's 13F filing for Q2 2019, filed 14 Aug 2019.